In the CKD population, circulating levels of prolactin are increased, which may result from reduced renal clearance (Yavuz et al., 2005) and reduced sensitivity to dopaminergic inhibition and thus upregulated production (Mckenna & Woolf, 1985). The gene discussed is PRL; the disease is chronic kidney disease.